Renal stone disease: A commentary on the nature and significance of randall's plaque: Commentary in response to a minireview by Johri et al. [Nephron Clin Pract 2010;116:159-171]

Nephron - Physiology

Volumn 119, Issue 4, 2011, Pages

  Evan, A P ^a   Unwin, R J ^b   Williams Jr , J C ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM OXALATE; CALCIUM PHOSPHATE; CALCIUM SALT; URATE;

AUTOPSY; CALCIUM OXALATE STONE; CELL ADHESION; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; CRYSTAL STRUCTURE; CRYSTALLIZATION; CYSTINURIA; ELECTRON MICROSCOPY; EVIDENCE BASED MEDICINE; HISTOPATHOLOGY; HUMAN; HYPERPARATHYROIDISM; HYPOTHESIS; IDIOPATHIC CALCIUM OXALATE STONE FORMER; ILEOSTOMY; KIDNEY CALCIFICATION; KIDNEY FIBROSIS; KIDNEY INTERSTITIUM; KIDNEY PAPILLA; KIDNEY TUBULE; KIDNEY TUBULE EPITHELIUM; MICROSCOPY; NEPHROLITHIASIS; NEPHRON; NOTE; PATHOPHYSIOLOGY; PEER REVIEW; PRIORITY JOURNAL; RISK FACTOR; URINE; UROLITHIASIS;

CALCIUM OXALATE; CALCIUM PHOSPHATES; CRYSTALLIZATION; DISEASE PROGRESSION; HUMANS; KIDNEY; KIDNEY CALCULI; RISK FACTORS;

EID: 82955207127     PISSN: 16602110     EISSN: 16602137     Source Type: Journal    
DOI: 10.1159/000330255     Document Type: Note

References (20)

1. Johri N, Cooper B, Roberson W, Choong S, Rickards D, Unwin R: An update and practical guide to renal stone management. Neph-ron Clin Pract 2010; 116: 159-171.
2. Asselman M, Verhulst A, Van Balegooijen ES, Bangma CH, Verkoelen CF, De Broe ME: Hyaluronan is apically secreted and expressed by proliferating or regenerating renal tubular cells. Kidney Int 2005; 68:71-83. (Pubitemid 43181365)
3. Randall A: The origin and growth of renal calculi. Ann Surg 1937; 105:1009-1027.
4. Randall R: Papillary pathology as precursor of primar y renal ca lculus. J Urol 1940; 44: 580-589.
5. Coe FL, Evan AP, Worcester EM, Lingeman JE: Three pathways for human kidney stone formation. Urol Res 2010; 38:147-160.
6. Coe FL, Evan AP, Lingeman JE, Worcester EM: Plaque and deposits in nine human stone diseases. Urol Res 2010; 38: 263-269.
7. Evan AP, Lingeman JE, Coe FL, Parks JH, Bledsoe SM, Shao Y, Sommer A, Paterson R, Kuo R, Grynpas M: Randall plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest 2003; 111:607-616. (Pubitemid 36278579)
8. Evan AP, Coe FL, Gillen D, Lingeman JE, Bledsoe S, Worcester EM: Renal intralumi-nal crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones. Anat Rec 2008; 291:325-334.
9. Evan AP, Lingeman JE, Coe FL, Shao Y, Parks JH, Bledsoe SB, Sommer AJ, Paterson RJ, Kuo RL, Kim S, Grynpas M: Crystal associated nephropathy in patients with brushite neph-rolithiasis. Kidney Int 2005; 67:576-591. (Pubitemid 40139849)
10. Evan AP, Coe FL, Lingeman JE, Shao Y, Matlaga BR, Kim S., Bledsoe SB, Sommer AJ, Grynpas M, Philips CL, Worcester EM: Renal crystal deposits and histopathology of the kidney in cystinuria. Kidney Int 2006; 69: 2227-2235. (Pubitemid 43882110)
11. Evan AP, Lingeman JE, Coe F, Shao Y, Miller N, Matlaga B, Phillips C, Sommer A, Worcester EM: Renal histopathology of stone-forming patients with distal renal tubular acido-sis. K idney Int 2007; 71: 795-801. (Pubitemid 46624023)
12. Evan AP, Lingeman JE, Coe FL, Miller N, Bledsoe S, Sommer A, Williams J, Shao Y, Worcester E: Histopathology and surgical anatomy of patients with primary hyper-parathyroidism and calcium phosphate stones. Kidney Int 2008; 74: 223-229. (Pubitemid 351915086)
13. Evan AP, Lingeman JE, Coe FL, Bledsoe S, Sommer A, Williams J, Krambeck A, Worcester E: Divergence between intratubu-lar deposits and urine and stone composition in patients with ileostomy. Kidney Int 2009; 67:1081-1088.
14. Evan AP, Lingeman JE, Worcester EM, Bled-soe SB, Sommer AJ, Williams JC, Krambeck A, Philips C, Coe FL: Renal histopathology and crystal deposits in patients with small bowel resection and calcium oxalate stone disease. Kidney Int 2010; 78:310-317.
15. Evan AP, Coe FL, Rittling SR, Bledsoe SB, Shao Y, Worcester EM, Lingeman JE: Apatite plaque particles in inner medulla of kidneys of CaOx stone formers: osteopontin localization. Kidney Int 2005; 68:145-154. (Pubitemid 43181371)
16. Evan AP, Bledsoe S, Worcester EM, Coe FL, Lingeman JE, Bergsland KJ: Renal inter-a-trypsin inhibitor heavy chain 3 increase in calcium oxalate stone-forming patients. Kidney Int 2007; 72: 1503-1511. (Pubitemid 350197952)
17. Evan AP, Coe FL, Lingeman JE, Shao Y, Som-mer AJ, Bledsoe SB, Anderson JC, Worcester EM: Mechanism of formation of human calcium oxalate renal stones on Randall's plaque. Anat Rec 2007; 290:1315-1323. (Pubitemid 47573203)
18. Miller NL, Gillen DL, Williams JC, Evan AP, Bledsoe SB, Coe FL, Worcester EM, Matlaga BR, Munch LC, Lingeman JE: A formal test of the hypothesis that idiopathic calcium oxalate stones grow on Randall's plaque. BJU Int 2009; 103: 966-971.
19. Finlayson B, Reid F: The expectation of free and fixed particles in urinary stone disease. Invest Urol 1978; 15: 442-448. (Pubitemid 8347910)
20. Kok DJ, Khan SR: Calcium oxalate nephrolithiasis, a free or fixed particle disease. Kidney Int 1994; 46:847-854. (Pubitemid 24272044)